Skip to main content
. 2020 Jun 10;12:150. doi: 10.3389/fnagi.2020.00150

Figure 6.

Figure 6

The difference in CSF DHA levels by intervention arm in the ADCS sponsored DHA clinical trial. Older APOE4 carriers with mild AD had lower CSF DHA levels after 18 months of DHA supplementation. Adapted from Yassine et al. (2016b).